These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29364701)

  • 41. Intracerebroventricular injection of phoenixin alters feeding behavior and activates nesfatin-1 immunoreactive neurons in rats.
    Friedrich T; Schalla MA; Scharner S; Kühne SG; Goebel-Stengel M; Kobelt P; Rose M; Stengel A
    Brain Res; 2019 Jul; 1715():188-195. PubMed ID: 30930149
    [TBL] [Abstract][Full Text] [Related]  

  • 42. C-fos mRNA pattern and corticotropin-releasing factor neuronal activity throughout the brain of rats injected centrally with a prostaglandin of E2 type.
    Lacroix S; Valliéres L; Rivest S
    J Neuroimmunol; 1996 Nov; 70(2):163-79. PubMed ID: 8898725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thyroxine modulates corticotropin-releasing factor but not arginine vasopressin gene expression in the hypothalamic paraventricular nucleus of the developing Rat.
    Dakine N; Oliver C; Grino M
    J Neuroendocrinol; 2000 Aug; 12(8):774-83. PubMed ID: 10929090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypothalamic action of phoenixin to control reproductive hormone secretion in females: importance of the orphan G protein-coupled receptor Gpr173.
    Stein LM; Tullock CW; Mathews SK; Garcia-Galiano D; Elias CF; Samson WK; Yosten GL
    Am J Physiol Regul Integr Comp Physiol; 2016 Sep; 311(3):R489-96. PubMed ID: 27440717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuronal nitric oxide synthase inhibition differentially affects oxytocin and vasopressin secretion in salt loaded rats.
    Ventura RR; Giusti-Paiva A; Gomes DA; Elias LL; Antunes-Rodrigues J
    Neurosci Lett; 2005 May; 379(2):75-80. PubMed ID: 15823420
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced up-regulation of corticotropin-releasing hormone gene expression in response to restraint stress in the hypothalamic paraventricular nucleus of oxytocin gene-deficient male mice.
    Nomura M; Saito J; Ueta Y; Muglia LJ; Pfaff DW; Ogawa S
    J Neuroendocrinol; 2003 Nov; 15(11):1054-61. PubMed ID: 14622435
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Osmotic stress increases brain-derived neurotrophic factor messenger RNA expression in the hypothalamic supraoptic nucleus with differential regulation of its transcripts. Relation to arginine-vasopressin content.
    Aliaga E; Arancibia S; Givalois L; Tapia-Arancibia L
    Neuroscience; 2002; 112(4):841-50. PubMed ID: 12088743
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alterations in the central vasopressin and oxytocin axis after lesion of a brain osmotic sensory region.
    Oliveira GR; Franci CR; Rodovalho GV; Franci JA; Morris M; Rocha MJ
    Brain Res Bull; 2004 Jul; 63(6):515-20. PubMed ID: 15249117
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cultured hypothalamic explants from spontaneously hypertensive rats have decreased vasopressin and oxytocin content and release.
    Bennett BA; Clodfelter J; Sundberg DK; Morris M
    Am J Hypertens; 1989 Jan; 2(1):46-51. PubMed ID: 2914084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Time course of appearance and release of [35S]cysteine labelled neurophysins and peptides in the neurohypophysis.
    Russell JT; Brownstein MJ; Gainer H
    Brain Res; 1981 Feb; 205(2):299-311. PubMed ID: 6162515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Through the central V2, not V1 receptors influencing the endogenous opiate peptide system, arginine vasopressin, not oxytocin in the hypothalamic paraventricular nucleus involves in the antinociception in the rat.
    Yang J; Chen JM; Song CY; Liu WY; Wang G; Wang CH; Lin BC
    Brain Res; 2006 Jan; 1069(1):127-38. PubMed ID: 16409991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Upregulation of the expression of vasopressin gene in the paraventricular and supraoptic nuclei of the lithium-induced diabetes insipidus rat.
    Anai H; Ueta Y; Serino R; Nomura M; Kabashima N; Shibuya I; Takasugi M; Nakashima Y; Yamashita H
    Brain Res; 1997 Oct; 772(1-2):161-6. PubMed ID: 9406968
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcription factor CREB3L1 mediates cAMP and glucocorticoid regulation of arginine vasopressin gene transcription in the rat hypothalamus.
    Greenwood M; Greenwood MP; Mecawi AS; Loh SY; Rodrigues JA; Paton JF; Murphy D
    Mol Brain; 2015 Oct; 8(1):68. PubMed ID: 26503226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of estrogen and progesterone on corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid levels in the paraventricular nucleus and supraoptic nucleus of the rhesus monkey.
    Roy BN; Reid RL; Van Vugt DA
    Endocrinology; 1999 May; 140(5):2191-8. PubMed ID: 10218971
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intensive venous sampling of adrenocorticotropic hormone in rats with sham or paraventricular nucleus lesions.
    Boyle LL; Brownfield MS; Lent SJ; Goodman B; Vo-Hill H; Litwin J; Carnes M
    J Endocrinol; 1997 Apr; 153(1):159-67. PubMed ID: 9135580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mineralocorticoid treatment attenuates activation of oxytocinergic and vasopressinergic neurons by icv ANG II.
    Roesch DM; Blackburn-Munro RE; Verbalis JG
    Am J Physiol Regul Integr Comp Physiol; 2001 Jun; 280(6):R1853-64. PubMed ID: 11353692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coexpression of glucagon-like peptide-1 (GLP-1) receptor, vasopressin, and oxytocin mRNAs in neurons of the rat hypothalamic supraoptic and paraventricular nuclei: effect of GLP-1(7-36)amide on vasopressin and oxytocin release.
    Zueco JA; Esquifino AI; Chowen JA; Alvarez E; Castrillón PO; Blázquez E
    J Neurochem; 1999 Jan; 72(1):10-6. PubMed ID: 9886049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding.
    Kohno D; Nakata M; Maejima Y; Shimizu H; Sedbazar U; Yoshida N; Dezaki K; Onaka T; Mori M; Yada T
    Endocrinology; 2008 Mar; 149(3):1295-301. PubMed ID: 18048495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Galanin influences vasopressin and oxytocin release from the hypothalamo-neurohypophysial system of salt loaded rats.
    Cisowska-Maciejewska A; Ciosek J
    J Physiol Pharmacol; 2005 Dec; 56(4):673-88. PubMed ID: 16391423
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CO(2)-induced c-Fos expression in hypothalamic vasopressin containing neurons.
    Kc P; Haxhiu MA; Trouth CO; Balan KV; Anderson WA; Mack SO
    Respir Physiol; 2002 Jan; 129(3):289-96. PubMed ID: 11788132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.